DCM
ABT icon

Deuterium Capital Management’s Abbott ABT Stock Holding History

Deuterium Capital Management’s Portfolio ABT Stock Details ABT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,276
Closed -$360K – 92
2022
Q4 		$360K Buy
+3,276
New +$339K 0.95% 33
2022
Q3 		– Sell
-2,648
Closed -$288K – 35
2022
Q2 		$288K Hold
2,648
– – 0.98% 25
2022
Q1 		$313K Buy
+2,648
New +$328K 0.4% 40

Other funds holding ABT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deuterium Capital Management's ABT Position: Q1 2023 in Review

Deuterium Capital Management sold out of Abbott (ABT) in Q1 2023, closing a stake of 3,276 shares — an estimated $360K sold.

Deuterium Capital Management first reported a position in ABT in Q1 2022 and held it in 3 quarters. The position peaked at $360K in Q4 2022. 2,704 funds tracked by Wall St. Rank hold ABT as of Q1 2023.

  • Deuterium Capital Management reported no remaining Abbott position as of Q1 2023 after selling out during the quarter.
  • Deuterium Capital Management sold 3,276 Abbott shares in Q1 2023, an estimated $360K.
  • Deuterium Capital Management first reported a position in Abbott in Q1 2022 and held it in 3 quarters.
  • Deuterium Capital Management's Abbott position peaked at $360K in Q4 2022.
  • 2,704 funds tracked by Wall St. Rank held Abbott as of Q1 2023.

Based on Deuterium Capital Management's 13F filing for Q1 2023, filed 12 May 2023.